Oakland, Calif.-based Kaiser Permanente led the fundraising round, along with D1 Capital Partners and Breyer Capital. Existing investors General Catalyst and 7wire Ventures, among others, also participated.
OM1 uses standardized health information and AI to gather and synthesize clinical data registries and help users compare and predict health outcomes. The company is partnered with providers, payers, manufacturers and medical societies and specifically supports chronic disease areas such as dermatology, rheumatology, cardiology, gastroenterology and neurosciences.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
